Cathie Wood Dumps Tech Stocks for Gene-Editing Plays in CRISPR and Beam
admin
TLDR Cathie Wood’s ARK Invest purchased $10. 06 million worth of CRISPR Therapeutics shares and $7. 06 million in Beam Therapeutics stock on November 4, 2025. ARK reduced technology holdings…